A. Schobel

A. Schobel

Chief Tech/Sci/R&D Officer at AQUESTIVE THERAPEUTICS, INC.

Net worth: 4 M $ as of 2024-04-29

68 year
Health Technology
Process Industries
Technology Services

Profile

A.
Mark Schobel
is currently the Director at Cecilian Partners, LLC.
He is also the Chief Technology & Innovation Officer at Aquestive Therapeutics, Inc. since 2015.
Additionally, he holds the position of Head-Public Relations at MonoSol LLC.
In the past, Mr. Schobel worked as the Principal at Pharmaceutical Formulations, Inc. and Warner-Lambert Co. He was also the Global Head-New Technology at Novartis Corp.
from 2001 to 2005.
Furthermore, he held the position of Principal at Reed & Carnrick Pharmaceuticals.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-14 984,476 ( 1.09% ) 4 M $ 2024-04-29

A. Schobel active positions

CompaniesPositionStart
AQUESTIVE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2014-10-31
MonoSol LLC /Laundry Bag Business/ Investor Relations Contact -
Director/Board Member -
All active positions of A. Schobel

Former positions of A. Schobel

CompaniesPositionEnd
Corporate Officer/Principal -
Reed & Carnrick Pharmaceuticals Corporate Officer/Principal -
Pharmaceutical Formulations, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of A. Schobel's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of A. Schobel's experience

Connections

61

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
AQUESTIVE THERAPEUTICS, INC.

Health Technology

Private companies6
MonoSol LLC /Laundry Bag Business/

Process Industries

Health Technology

Health Technology

Pharmaceutical Formulations, Inc.

Health Technology

Reed & Carnrick Pharmaceuticals

Technology Services

See company connections